Use of serum uPA change to predict PFS and overall survival in first-line trastuzumab-treated breast cancer

被引：0
作者：
Hou, H. Y.
Anyanwu, U.
Jamshidi, N.
Leitzel, K.
Ali, S. M.
Koestler, W.
Fuchs, E.
Hamer, P.
Carney, W. P.
Lipton, A.
机构：
[1] Penn State Hershey Med Ctr, Hershey, PA USA
[2] Lebanon VA Med Ctr, Lebanon, PA USA
[3] Med Univ Vienna, Vienna, Austria
[4] Siemens Healthcare Diagnost, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.1050
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1050
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Overall survival and associated factors in women with metastatic breast cancer treated with trastuzumab at a public referral institution
    Goncalves, Debora Silva
    Migowski, Arn
    da Costa, Susanne Crocamo Ventilari
    da Costa, Rodrigo Saar
    Simoes e Senna, Katia Marie
    Zimmermann, Ivan Ricardo
    [J]. REVISTA BRASILEIRA DE EPIDEMIOLOGIA, 2023, 26
  • [42] Conditional Survival of Patients Treated With First-Line Chemotherapy for Metastatic Urothelial Cancer
    Santoni, Matteo
    Crabb, Simon J.
    Conti, Alessandro
    Rossi, Lorena
    Burattini, Luciano
    Conteduca, Vincenza
    Chau, Caroline
    Burgio, Salvatore L.
    Muzzonigro, Giovanni
    Cascinu, Stefano
    De Giorgi, Ugo
    [J]. CLINICAL GENITOURINARY CANCER, 2015, 13 (03) : 244 - 249
  • [43] First-line, single-agent Herceptin® (trastuzumab) in metastatic breast cancer:: a preliminary report
    Vogel, C
    Cobleigh, MA
    Tripathy, D
    Gutheil, JC
    Harris, LN
    Fehrenbacher, L
    Slamon, DJ
    Murphy, M
    Novotny, WF
    Burchmore, M
    Shak, S
    Stewart, SJ
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 : S25 - S29
  • [44] CA 19-9 SERUM CONCENTRATIONS - ANALYSIS OF THE SERUM KINETICS DURING FIRST-LINE THERAPY OF PANCREATIC CANCER IN RELATION TO OVERALL SURVIVAL
    Klapdor, R.
    Bahlo, M.
    Babinski, A.
    Klapdor, S.
    [J]. ANTICANCER RESEARCH, 2008, 28 (6B) : 4016 - 4017
  • [45] CA19-9 Serum Concentrations - Analysis of the Serum Kinetics During First-line Therapy of Pancreatic Cancer in Relation to Overall Survival
    Klapdor, R.
    Bahlo, M.
    Babinski, A.
    Klapdor, S.
    [J]. ANTICANCER RESEARCH, 2010, 30 (05) : 1869 - 1874
  • [46] A quantitative study of tumor response and progression-free survival as surrogate endpoints for overall survival in first-line treatment of metastatic breast cancer
    Burzykowski, T
    Piccart, MJ
    Sledge, G
    Carmichael, J
    Luck, HJ
    Mackey, JR
    Nabholtz, JM
    Paridaens, R
    Biganzoli, L
    Jassem, J
    Blohmer, JU
    Bontenbal, M
    Bonneterre, J
    Chan, S
    Atalay, G
    Therasse, P
    Buyse, M
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S277 - S278
  • [47] Impact of cachexia on survival before first-line chemotherapy for metastatic breast cancer
    Nozawa, Kazuki
    Isogai, Ayaka
    Takatsuka, Daiki
    Endo, Yuka
    Ozaki, Yuri
    Horisawa, Nanae
    Kataoka, Ayumi
    Kotani, Haruru
    Yoshimura, Akiyo
    Hattori, Masaya
    Sawaki, Masataka
    Iwata, Hiroji
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S491 - S492
  • [48] An estimation of the population survival benefit of first-line chemotherapy and immunotherapy for breast cancer
    Delaney, G. P.
    Do, V.
    Ng, W.
    Barton, M. B.
    [J]. CANCER RESEARCH, 2017, 77
  • [49] Long-term responders to trastuzumab monotherapy in first-line HER-2+advanced breast cancer: characteristics and survival data
    Schmid, Sabine
    Klingbiel, Dirk
    Aebi, Stefan
    Goldhirsch, Aron
    Mamot, Christoph
    Munzone, Elisabetta
    Nole, Franco
    Oehlschlegel, Christian
    Pagani, Olivia
    Pestalozzi, Bernhard
    Rochlitz, Christoph
    Thuerlimann, Beat
    von Moos, Roger
    Weder, Patrik
    Zaman, Khalil
    Ruhstaller, Thomas
    [J]. BMC CANCER, 2019, 19 (01)
  • [50] Fulvestrant 500 mg versus anastrozole as first-line treatment for advanced breast cancer: Overall survival from the Phase II 'FIRST' study
    Robertson, John F. R.
    Llombart-Cussac, Antonio
    Feltl, David
    Dewar, John
    Jasiowka, Marek
    Hewson, Nicola
    Rukazenkov, Yuri
    Ellis, Matthew J.
    [J]. CANCER RESEARCH, 2015, 75
12345